Saturday 17 October 2026 Export CERS’s income statement to Excel — free account

Cerus Corporation

In the quarter to June 2026, revenue grew 5.28%, EPS grew 50.3%, free cash flow fell 20.9% and total debt fell 23.5%, each against the same quarter a year earlier.

2.20 0.06 −2.65%

Follow CERS

Alert me

Market cap: $455.5M
P/E: 0.0×
Fwd P/E: −81.3×
Dividend yield: —
F-score: 5/9
Altman Z: −4.00
Beneish M: −2.87
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 3.09

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	—	—	—	9	—	2	5	1	1	—	—

Insider Ownership 4.93%

Capital & Financial Ratios $m

Market Cap 455.45

Revenue 248.01

Net Income (6.83)

Free Cash Flow (1.83)

Net Debt 8.65

Current Ratio 1.83

Debt/Equity 0.92

P/E ratio 0.00

Fwd P/E (81.30)

P/S ratio 1.78

P/B ratio 6.24

Past 5Y EPS Growth —

This Y EPS Growth 43.75%

Next Y EPS Growth 72.22%

Next Y revenue growth 6.50%

Next 5Y EPS Growth 54.33%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 18.91%

10-year low 10-year high

P/B against its own 10 years 20.68%

10-year low 10-year high

EV/Sales against its own 10 years 19.06%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	66	80	83	56
Receivables	36	30	30	31
Inventory	40	38	56	66
Other	—	—	—	—
	144	152	174	157

	2023	2024	2025	Q'26
Payables	24	22	28	34
ST’ Debt	20	19	43	30
Other	—	—	—	—
	68	64	101	86

Compound Annual Growth %

	10y	5y	3y
Sales	21.19%	15.40%	7.48%
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	(3.71%)	(8.95%)	(1.78%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	60	63	—	—	—
’25	49	60	60	65	234
’24	43	51	51	57	201
’23	38	48	47	53	187
’22	43	48	46	51	188
’21	30	38	42	50	160
’20	25	27	29	34	114

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(3)	(3)	—	—	—
’25	(1)	(2)	2	6	5
’24	2	0	4	5	11
’23	(8)	(9)	(10)	(15)	(43)
’22	(21)	0	(2)	(2)	(26)
’21	(17)	(9)	(7)	(1)	(34)
’20	(20)	(8)	(5)	(9)	(42)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(3)	(4)	—	—	—
’25	(1)	(3)	0	5	1
’24	1	0	3	4	9
’23	(10)	(9)	(13)	(15)	(48)
’22	(22)	0	(3)	37	12
’21	(18)	(9)	(7)	(2)	(35)
’20	(20)	(8)	(5)	(9)	(43)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.01)	(0.01)	—	—	—
’25	(0.04)	(0.03)	0.00	(0.01)	(0.08)
’24	(0.05)	(0.03)	(0.02)	(0.01)	(0.11)
’23	(0.09)	(0.07)	(0.04)	(0.01)	(0.21)
’22	(0.07)	(0.05)	(0.05)	(0.08)	(0.24)
’21	(0.10)	(0.09)	(0.07)	(0.05)	(0.32)
’20	(0.10)	(0.09)	(0.08)	(0.09)	(0.37)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	4.17	1.93	3.38	3.70	2.71	4.67	3.25	1.21	1.38	1.12	Analyst estimates 2026–2028 Powerpack
	High	7.64	4.70	8.05	6.88	8.87	8.41	7.01	4.05	2.59	2.26
People
People	Employees	204	215	240	254	270	294	309	288	281	275
	Revenue/emp, $m	0.19	0.24	0.32	0.37	0.42	0.54	0.61	0.65	0.72	0.85
Income, $m
Income, $m	Revenue	39	51	76	94	114	160	188	187	201	234
	Gross margin, %	48.33	56.10	58.40	64.36	63.98	60.21	60.20	62.54	59.89	59.86
	EBT	(63)	(57)	(57)	(71)	(60)	(54)	(42)	(37)	(21)	(15)
	EBT margin, %	(159.72)	(110.47)	(75.39)	(75.69)	(52.14)	(33.89)	(22.48)	(19.98)	(10.31)	(6.54)
	Net income	(63)	(61)	(58)	(71)	(60)	(54)	(43)	(38)	(21)	(16)
	Depreciation	2	2	1	2	3	3	3	3	2	1
Per share, $
Per share, $	Revenue	0.39	0.47	0.58	0.67	0.70	0.93	1.07	1.04	1.09	1.23
	Earnings	(0.62)	(0.56)	(0.44)	(0.51)	(0.37)	(0.32)	(0.24)	(0.21)	(0.11)	(0.08)
	Cash flow	(0.53)	(0.48)	(0.24)	(0.47)	(0.25)	(0.20)	(0.15)	(0.24)	0.06	0.03
	Capex	(0.01)	0.00	(0.01)	(0.06)	(0.01)	(0.01)	0.22	(0.03)	(0.02)	(0.02)
	Free cash flow	(0.53)	(0.49)	(0.25)	(0.53)	(0.26)	(0.20)	0.07	(0.26)	0.05	0.01
	Book value	0.57	0.36	0.64	0.41	0.63	0.50	0.39	0.30	0.31	0.34
	Shares, m	102	108	132	140	164	171	177	180	185	191
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	11.23	7.51	8.78	6.29	9.93	7.31	3.51	2.08	1.41	1.68
	P/B	7.63	9.89	7.90	10.34	10.93	13.62	9.63	7.29	5.00	6.04
	EV/Sales	9.90	7.01	7.62	5.85	9.18	6.94	3.33	2.16	1.43	1.68
	EV/FCF	(7.18)	(6.84)	(17.90)	(7.37)	(24.16)	(31.77)	50.28	(8.44)	33.79	355.26
Cash, $m
Cash, $m	Operating cash flow	(54)	(52)	(31)	(65)	(42)	(34)	(26)	(43)	11	5
	Capex	(1)	0	(1)	(9)	(2)	(1)	38	(5)	(3)	(4)
	Free cash flow	(54)	(53)	(32)	(74)	(43)	(35)	12	(48)	9	1
Balance, $m
Balance, $m	Working capital	67	67	94	78	123	109	53	77	88	74
	Total debt	19	30	30	44	48	69	70	80	84	84
	Net debt	(52)	(31)	(88)	(41)	(85)	(60)	(32)	14	4	1
	Shareholders’ equity	58	39	85	57	104	86	69	53	57	65
Returns, %
Returns, %	ROA	(51.80)	(60.07)	(43.99)	(43.31)	(30.94)	(23.70)	(18.78)	(18.03)	(10.49)	(7.39)
	ROIC	(693.97)	(447.11)	0.00	(262.55)	(199.05)	(119.11)	(58.82)	(27.87)	(14.67)	(8.22)
	ROE	(82.47)	(125.27)	(93.25)	(100.65)	(74.42)	(57.41)	(55.49)	(61.45)	(37.92)	(25.65)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
TCMD Tactile Systems Technology, Inc.	$527.6M	20.5×	22.7×	+8.61% (above 0%: growing)	+142.86% (above 0%: growing)	−86.53% (below 0%: shrinking)	76.25%	7.97%	Compare
SSII SS Innovations International, Inc.	$517.2M	— (loss-making)	— (loss-making)	+39.39% (above 0%: growing)	n/m	−16.62% (below 0%: shrinking)	50.94%	(16.29%)	Compare
DCTH Delcath Systems, Inc.	$513.9M	1,408×	— (loss-making)	+20.60% (above 0%: growing)	−12.50% (below 0%: shrinking)	−24.45% (below 0%: shrinking)	89.75%	8.22%	Compare
MASS 908 Devices Inc.	$491.5M	— (loss-making)	— (loss-making)	+23.31% (above 0%: growing)	n/m	+150.95% (above 0%: growing)	51.90%	(79.69%)	Compare
SGHT Sight Sciences, Inc.	$484.8M	— (loss-making)	— (loss-making)	+19.55% (above 0%: growing)	n/m	+26.71% (above 0%: growing)	91.39%	(16.62%)	Compare
BWAY Brainsway Ltd. Sponsored ADR	$475.8M	24.8×	— (loss-making)	+35.43% (above 0%: growing)	+40.00% (above 0%: growing)	−51.68% (below 0%: shrinking)	74.62%	13.98%	Compare
CERS Cerus Corporation	$455.5M	— (loss-making)	— (loss-making)	+5.28% (above 0%: growing)	n/m	−20.90% (below 0%: shrinking)	55.91%	(2.94%)
NPCE NeuroPace, Inc.	$438.7M	— (loss-making)	— (loss-making)	+17.05% (above 0%: growing)	n/m	−78.70% (below 0%: shrinking)	82.83%	(22.53%)	Compare
SENS Senseonics Holdings, Inc.	$435.2M	— (loss-making)	— (loss-making)	+117.82% (above 0%: growing)	n/m	−223.24% (below 0%: shrinking)	59.10%	(248.48%)	Compare
Median of peers	$488.1M	24.8×	—	+21.96%	+40.00%	−38.07%	75.44%	(16.45%)

All 149 Medical Devices stocks →

Cerus Corporation (CERS) key facts

Cerus Corporation (CERS) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, CERS traded at $2.20, a market capitalization of $455.5 million.
Return on equity was −25.7% and debt-to-equity 0.92.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is −4.00 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.